| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 |
| Total Revenue | 532 | 682 | 379 | 172 |
| Cost of Revenue | 348 | 447 | 233 | 113 |
|
| Gross Profit | 185 | 235 | 146 | 59 |
|
| Operating Expenses |
| Research Development | 32 | 28 | 26 | 89 |
| Selling General and Administrative | 166 | 247 | 260 | 569 |
| Non Recurring | 0 |
-
|
-
| 0 |
| Others | 8 | 8 | 7 | 8 |
| |
| Total Operating Expenses | 206 |
-
|
-
| 666 |
|
|
| Operating Income or Loss | (21) | (48) | (148) | (607) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 12 | (12) | (0) | (19) |
| Earnings Before Interest And Taxes | (9) | (60) | (148) | (626) |
| Interest Expense |
-
| (6) | 6 | 19 |
| Income Before Tax | (9) | (54) | (154) | (645) |
| Income Tax Expense |
-
|
-
|
-
|
-
|
| Minority Interest |
-
|
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | (9) | (54) | (154) | (645) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income | (9) | (54) | (154) | (645) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | ($9) | ($54) | ($154) | ($645) |
0.31% Nasdaq 0.00%
Income Statement
